The Wegovy-specific part: you are stopping from higher
Wegovy titrates to 2.4mg weekly, the highest standard semaglutide dose. Ozempic tops out at 2mg and is frequently held at 0.5 or 1mg for blood sugar. Same molecule, same 7-day half-life, but the height you fall from differs, and that height is what determines how concentrated the transition feels.
This is also why the label option matters. The Wegovy prescribing information explicitly permits a permanent reduction from 2.4mg to 1.7mg when the top dose is not tolerated. A lower ongoing dose is a documented, label-sanctioned path, not a hack, and it is worth raising with your prescriber before assuming the only options are full dose or zero. The microdosing chart maps that middle territory and grades the evidence for each version of it.
The washout timeline
Semaglutide's half-life is about 7 days, so after your last 2.4mg dose: roughly 50% remains at one week, 25% at two weeks, 12% at three, and it is essentially cleared by week five. Date your own curve with the washout calculator.
Still substantially active. Most people feel normal. Expect a 2 to 6 lb scale rise from fluid, not fat.
Portions stop self-limiting. Satiety shortens. First flickers of food noise.
The hard zone. From 2.4mg this is the most pronounced stretch: appetite can rebound above your pre-drug baseline while your body burns several hundred fewer calories a day than before the loss.
The regain window in the trials. Also when non-food improvements (sleep, joints, cycles, reduced drinking) may drift back.
Cold turkey vs tapering: the honest comparison
| Stopping outright | Stepping down | |
|---|---|---|
| Transition shape | One concentrated window, weeks 3 to 6 | Spread across months, in smaller slices |
| Cost and side effects | Ends immediately | Continues through the step-down |
| Evidence for weight outcomes | Regain well documented without support (STEP-1 extension) | Plausible advantage, unproven in trials; one coaching cohort held stable at 6 months |
| Most common real reason | Insurance, supply, or cost ended the decision | Reached goal and planned the exit |
Many people stopping Wegovy do not get to choose. If a denial letter or a supply problem made the decision, the injustice is real and the biology is unchanged: the same structure works either way. The full taper conversation, including what to ask your prescriber, is in how to wean off.
Side effects after stopping Wegovy
What people actually report, in rough order of frequency:
- Hunger returning, sometimes above the pre-drug baseline for a period
- Food noise coming back in weeks 2 to 6 (see what food noise is)
- GI side effects resolving: nausea, constipation and sulfur burps typically clear as stomach emptying normalizes
- Fatigue or low mood during the transition, commonly reported though not a documented withdrawal effect
- Metabolic markers drifting: blood pressure and cholesterol improvements can reverse alongside weight
Worth naming clearly: none of this is withdrawal in the medical sense. Semaglutide does not produce a physical dependence syndrome. What returns is your own biology, minus a signal that was being supplied from outside.
Stopping oral Wegovy is a different story
The semaglutide pill launched in January 2026 and crossed three million prescriptions by June, one of the strongest US pharmaceutical launches on record. If that is what you are on, several things about stopping change:
- The taper conversation is different. The pill is a daily 25mg dose rather than a weekly injection at one of five rungs. There is no dose ladder to walk down in the same way, which makes "stop or continue" a blunter choice and makes the prescriber conversation more important, not less.
- Drifting off is trivially easy. A weekly injection has a ritual attached: shot day, a pen in the fridge, a countdown you notice. A daily pill has none of that. People miss two days, then five, then realize a fortnight later that they stopped without ever deciding to. The washout clock started at that first missed dose, not at the moment you noticed.
- The molecule and the timeline are unchanged. It is still semaglutide, still roughly a 7-day half-life, still essentially cleared about five weeks after the true last dose. Everything on the washout calculator applies, as long as you date it from the real last dose.
- Absorption rules make missed doses more likely. Oral semaglutide needs an empty stomach and a wait before eating. That friction is exactly the kind that erodes adherence quietly over months.
If you are not sure when you actually stopped, work backward to the last day you are confident you took it and use that date. Being a week out on the estimate is fine; the phases are wide. What matters is not assuming the clock starts when you noticed, because that puts you further into the transition than you think and makes an ordinary week-4 appetite return feel like something has gone wrong.
One broader note worth having: because more than 80% of new oral prescriptions have gone to people who never used an injectable, a very large group is heading toward their first discontinuation window with no prior experience of what coming off feels like. If that is you, the timeline below is the whole point of reading this.
What holds the result
Same five levers regardless of dose or exit style: a protein floor near 1.6g per kg of goal weight split across three meals, two or three short resistance sessions a week to defend muscle, recalculated calorie targets for a body burning 300 to 500 fewer calories a day, a smoothed weight trend that catches drift at 4 lbs instead of 20, and a pre-built response to food noise. The detailed version is in how to not gain the weight back.